Dj%252525252525252525252525252520citral

# Citral (3,7-Dimethyl-2,6-octadienal) ## Overview Citral is an acyclic monoterpene aldehyde consisting of a mixture of geometric isomers (geranial and neral). It is primarily used as a flavoring agent and fragrance component. It possesses distinct antimicrobial, anti-inflammatory, and sedative properties in preclinical models, but lacks established clinical utility as a pharmaceutical drug. It is not an FDA-approved prescription medication. ## Primary Indications Currently, there are no clinically approved therapeutic indications for citral. It is primarily utilized in the food, cosmetic, and perfumery industries. Experimental research has explored its use as a natural antimicrobial agent or potential sedative, but these applications are not clinically validated. ## Adult Dosing No standard medical dosing exists. As a food additive, it is regulated as "Generally Recognized as Safe" (GRAS) by the FDA when used in accordance with strictly defined limitations. Therapeutic use is not recommended until appropriate clinical trials establish safety and efficacy. ## Pediatric Dosing No established pediatric dosage exists. Use in pediatric populations is not advised due to significant risk of contact dermatitis and sensitization. ## Dose Adjustments There are no established protocols for dose adjustment in patients with hepatic or renal impairment. ## Contraindications Hypersensitivity to citral or its metabolic derivatives. Patients with a known history of severe contact dermatitis or fragrance allergies should avoid exposure. ## Adverse Effects The most common adverse effect is **allergic contact dermatitis**. Citral is categorized as a potent skin sensitizer. Other potential effects include mucosal irritation, photosensitivity, and, with ingestion of high concentrations, theoretical neurotoxicity or metabolic disruption. ## Key Drug Interactions There is limited clinical data regarding drug interactions. Theoretically, given its metabolic pathway, it may interact with CYP450-mediated metabolism. Until specific interaction studies are performed, assume potential for additive effects with other sedative or anti-inflammatory agents. ## Monitoring Not applicable in a clinical context. If used experimentally or topically, clinical monitoring for signs of sensitization, such as erythema, pruritus, or vesicular eruptions, is required. ## Clinical Pearls - **Sensitization Risk:** Citral is highly reactive; it is considered one of the common allergens in the fragrance industry. - **Regulatory Status:** While GRAS as a flavoring agent, the concentration in food items is strictly limited to prevent systemic toxicity. - **Do Not Substitute:** This agent should not be substituted for conventional medications in the treatment of infection or inflammation. - **Oxidation:** Citral is unstable and sensitive to air/light; oxidation products (such as p-menthane derivatives) significantly increase the risk of skin sensitization. *** **Educational Disclaimer:** This information is for educational purposes only. Citral is not an FDA-approved pharmaceutical drug. Please verify current prescribing information, institutional protocols, and safety data sheets (SDS) before considering the use of any chemical substance. Always consult a licensed healthcare professional for clinical decision-making.